avelumab
Bavencio Receives New Indication for Maintenance in Advanced Urothelial Carcinoma
The FDA granted a new indication for avelumab for the maintenance treatment of patients with locally advanced or ...
JULY 6, 2020
First-Line Avelumab-Axitinib Combo Increases PFS for Patients With Advanced RCC
First-line treatment combining the immune checkpoint blocker avelumab (Bavencio, EMD Serono/Pfizer) with the ...
JANUARY 24, 2019
Long-Term Benefit Seen With Avelumab in Merkel Cell Ca
Washington—Avelumab was associated with a rate of survival in patients with metastatic Merkel cell carcinoma ...
JUNE 20, 2017
Bavencio Approved for Bladder Cancer
The drug was approved for the treatment of patients with locally advanced or metastatic urothelial carcinoma whose ...
MAY 10, 2017
FDA Approves First Treatment for MCC
The drug was approved for the treatment of adults and pediatric patients 12 years and older with metastatic MCC, ...
MARCH 23, 2017
Avelumab Granted Priority Review to Treat Metastatic Merkel Cell Carcinoma
A review has been submitted for the proposed use of the investigational immunotherapy in patients with metastatic ...
NOVEMBER 29, 2016